TY  - GEN
AU  - Saeed,Omar
AU  - Shah,Aman
AU  - Kargoli,Faraj
AU  - Madan,Shivank
AU  - Levin,Allison P
AU  - Patel,Snehal R
AU  - Jermyn,Rita
AU  - Guerrero,Cesar
AU  - Nguyen,Jenni
AU  - Sims,Daniel B
AU  - Shin,Julia
AU  - D'Alessandro,David
AU  - Goldstein,Daniel J
AU  - Jorde,Ulrich P
TI  - Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support
SN  - 1941-3297
PY  - 2016///0427
KW  - Adult
KW  - Aged
KW  - Anticoagulants
KW  - adverse effects
KW  - Aspirin
KW  - Chi-Square Distribution
KW  - Dipyridamole
KW  - Disease-Free Survival
KW  - Drug Therapy, Combination
KW  - Female
KW  - Heart Failure
KW  - blood
KW  - Heart-Assist Devices
KW  - Hemorrhage
KW  - chemically induced
KW  - Humans
KW  - International Normalized Ratio
KW  - Kaplan-Meier Estimate
KW  - Linear Models
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - New York City
KW  - epidemiology
KW  - Platelet Aggregation Inhibitors
KW  - Prevalence
KW  - Proportional Hazards Models
KW  - Prosthesis Design
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Risk Factors
KW  - Thrombosis
KW  - diagnosis
KW  - Time Factors
KW  - Treatment Outcome
KW  - Ventricular Function, Left
KW  - Warfarin
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1161/CIRCHEARTFAILURE.115.002296
ER  -